Thyroid投稿须知_审稿周期

期刊简介

《Thyroid》是由Mary Ann Liebert Inc.出版社于1990年创办的英文国际期刊（ISSN: 1050-7256，E-ISSN: 1557-9077），该期刊长期致力于内分泌学与代谢领域的创新研究，主要研究方向为医学-内分泌学与代谢。作为SCIE收录期刊（JCR分区 Q1，中科院 1区），本刊采用OA未开放获取模式（OA占比0.0590...%），以发表内分泌学与代谢领域等方向的原创性研究为核心（研究类文章占比92.97%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在128篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Thyroid审稿周期约为约6月。该刊近年未被列入国际预警名单，年发文量约128篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
128 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
是	否	医学 1区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢 1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
是	否	医学 1区	ENDOCRINOLOGY & METABOLISM 内分泌学与代谢 2区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	24 / 186	87.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ENDOCRINOLOGY & METABOLISM	SCIE	Q1	19 / 186	90.05%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：12.3

SJR：1.889

SNIP：2.076

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Endocrinology	Q1	9 / 128	93%
大类：Biochemistry, Genetics and Molecular Biology 小类：Endocrinology, Diabetes and Metabolism	Q1	19 / 244	92%

期刊发文

A Systematic Review and Meta-Analysis Examining the Risk of Adverse Pregnancy and Neonatal Outcomes in Women with Isolated Hypothyroxinemia in Pregnancy
Author: Han, Yutong; Gao, Xiaotong; Wang, Xichang; Zhang, Chenyu; Gong, Boshen; Peng, Bingcong; Li, Jiashu; Liu, Aihua; Shan, Zhongyan

Journal: THYROID. 2023; Vol. , Issue , pp. -. DOI: 10.1089/thy.2022.0600
Thyroid Autoimmunity Is Not Associated with Embryo Quality or Pregnancy Outcomes in Euthyroid Women Undergoing Assisted Reproductive Technology in China
Author: Rao, Meng; Zeng, Zhengyan; Zhang, Qiaoling; Su, Cunmei; Yang, Zexing; Zhao, Shuhua; Tang, Li

Journal: THYROID. 2023; Vol. 33, Issue 3, pp. 380-388. DOI: 10.1089/thy.2022.0184
Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer
Author: Qu, Huiling; Zhang, Ziqi; Zhang, Dalin; Okamoto, Takahiro; Zhang, Ping; Zhang, Hao; Dong, Wenwu

Journal: THYROID. 2023; Vol. , Issue , pp. -. DOI: 10.1089/thy.2022.0700
M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor
Author: Lu, Yi; Wang, Yi; Wang, Yang; Wu, Yu; Huang, Yazhuo; Liu, Xingtong; Zhang, Shuo; Zhong, Sisi; Li, Yinwei; Li, Bin; Sun, Jing; Fang, Sijie; Zhou, Huifang

Journal: THYROID. 2023; Vol. 33, Issue 3, pp. 338-350. DOI: 10.1089/thy.2022.0254
Letter to the Editor: Conditional Survival Rate Estimates for Anaplastic Thyroid Cancer Beyond the First Year: An Analysis of SEER Data (2004-2019)
Author: Dong, Wenwu; Okamoto, Takahiro; Ji, Xiaoyu; Xiang, Jingzhe; Zhang, Dalin; Zhang, Ping; Zhang, Hao

Journal: THYROID. 2023; Vol. , Issue , pp. -. DOI: 10.1089/thy.2022.0339
Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China
Author: Xu, Yingxi; Li, Chenyan; Wang, Weiwei; Yu, Xiaohui; Liu, Aihua; Shi, Yang; Xie, Xiaochen; Li, Jiashu; Li, Yongze; Shan, Zhongyan; Teng, Weiping; Li, Yushu

Journal: THYROID. 2023; Vol. , Issue , pp. -. DOI: 10.1089/thy.2022.0460
Health-Related Quality of Life and Thyroid Cancer-Specific Symptoms in Patients Treated for Differentiated Thyroid Cancer: A Single-Center Cross-Sectional Survey from Mainland China
Author: Chen, Changlian; Cao, Jiayan; Wang, Yueyang; Han, Xuya; Zhang, Yaju; Zhuang, Shumei

Journal: THYROID. 2023; Vol. , Issue , pp. -. DOI: 10.1089/thy.2022.0490
Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives
Author: Zhu, Pingting; Zhang, Qianqian; Wu, Qiwei; Shi, Guanghui; Wang, Wen; Xu, Huiwen; Zhang, Li; Qian, Meiyan; Hegarty, Josephine

Journal: THYROID. 2023; Vol. , Issue , pp. -. DOI: 10.1089/thy.2022.0347

Thyroid

甲状腺

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询